Brief: Neovacs Announces Positive Results For IFNalpha Kinoid In Type 1 Diabetes

Neovacs SA

12/12/2017 06:01

Dec 12 (Reuters) - NEOVACS SA  ALNEV.PA : 
    * NEOVACS ANNOUNCES POSITIVE RESULTS  FOR IFNALPHA KINOID IN 
TYPE 
1 DIABETES 
    * INTENDS TO CONTINUE PRECLINICAL DEVELOPMENT IN THIS 
INDICATION 
IN 2018 
    * EXPECTS TO COMPLETE THIS STUDY IN 2018 
    * A PHASE IIB STUDY IS CURRENTLY ONGOING WITH IFNALPHA 
KINOID FOR 
TREATMENT OF LUPUS 
 
Source text for Eikon:  ID:nGNE3W2tZr  
Further company coverage:  ALNEV.PA  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))